Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business

COVID-19 cases falling in U.S., Canada, but still rising in Latam, says PAHO

FILE PHOTO: A municipal employee digs up a grave at the El Centinela cemetery, amid the coronavirus disease (COVID-19) pandemic, in Mexicali, Baja California state, Mexico January 30, 2021. REUTERS/Victor Medina/File Photo

While coronavirus infections are finally decreasing in the United States and Canada after weeks of unrelenting rise, cases and deaths continue to increase in Latin American countries, the Pan American Health Organization said on Wednesday.

In Mexico cases are still rising, particularly in states that drew tourism in the holiday season, such as Guerrero, Quintana Roo, Nayarit and Baja California del Sur, the regional branch of the World Health Organization said in a briefing.

Across the Caribbean, most nations are seeing a reprieve in COVID-19 infections, but larger islands like the Dominican Republic, Haiti, Puerto Rico and Cuba continue to see rising numbers of new infections, it said.

In South America, Colombia reported the highest incidence of cases relative to its population over the past week, followed by Brazil, where the city of Manaus has been grappling with a surge in both cases and deaths, driven up by a new Amazon variant of the virus.

The new Brazil variant, as well as two others first identified in the United Kingdom and South Africa, have spread to 20 countries in the Americas, though their frequency is still limited, PAHO director Carissa Etienne said.

COVID-19 vaccines delivered by COVAX, a coalition led by the WHO and the Gavi vaccine alliance to ensure equitable access to the shots, will begin to arrive in the region in the second half of February, she said.

Peru, Bolivia, Colombia and El Salvador will receive a first lot of the Pfizer-BioNTech vaccine, said PAHO Assistant Director Jarbas Barbosa, while 35.3 million doses of AstraZeneca's shot will start arriving as soon as the WHO grants it emergency use approval.

The aim is to provide for 20% of the population in the countries participating in COVAX to protect those most at risk.

But Etienne warned that "vaccine doses are limited and will remain in short supply everywhere at first."

(Reporting by Anthony Boadle, Editing by Rosalba O'Brien)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.